Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Veesler

Showing results (111-120 of 226) with videos related to

Pageof 23
Sort By:
Plos Pathogens|February 8, 2022
A SARS-CoV-2 variant elicits an antibody response with a shifted immunodominance hierarchyAllison J Greaney, Tyler N Starr, Rachel T Eguia, et al.
Cell|December 3, 2025
The unique architecture of umbrella toxins permits a two-tiered molecular bet-hedging strategy for interbacterial antagonismQinqin Zhao, Jiri Vlach, Young-Jun Park, et al.
Cell|August 26, 2020
Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 BindingTyler N Starr, Allison J Greaney, Sarah K Hilton, et al.
Science (New York, N.Y.)|June 28, 2022
Shifting mutational constraints in the SARS-CoV-2 receptor-binding domain during viral evolutionTyler N Starr, Allison J Greaney, William W Hannon, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 26, 2022
Potent monoclonal antibody-mediated neutralization of a divergent Hendra virus variantZhaoqian Wang, Ha V Dang, Moushimi Amaya, et al.
Elife|November 8, 2018
Germline VRC01 antibody recognition of a modified clade C HIV-1 envelope trimer and a glycosylated HIV-1 gp120 coreAndrew J Borst, Connor E Weidle, Matthew D Gray, et al.
Nature|December 18, 2024
Hierarchical design of pseudosymmetric protein nanocagesQuinton M Dowling, Young-Jun Park, Chelsea N Fries, et al.
Biorxiv : the Preprint Server for Biology|January 5, 2021
Structural basis for broad coronavirus neutralizationMaximilian M Sauer, M Alexandra Tortorici, Young-Jun Park, et al.
Viruses|May 10, 2020
Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization AssaysKatharine H D Crawford, Rachel Eguia, Adam S Dingens, et al.
Immunity|October 14, 2020
HIV-1 VRC01 Germline-Targeting Immunogens Select Distinct Epitope-Specific B Cell ReceptorsYu-Ru Lin, K Rachael Parks, Connor Weidle, et al.
Pageof 23

Showing results (111-120 of 226) with videos related to

Sort By:
Pageof 23
Plos Pathogens|February 8, 2022
A SARS-CoV-2 variant elicits an antibody response with a shifted immunodominance hierarchyAllison J Greaney, Tyler N Starr, Rachel T Eguia, et al.
Cell|December 3, 2025
The unique architecture of umbrella toxins permits a two-tiered molecular bet-hedging strategy for interbacterial antagonismQinqin Zhao, Jiri Vlach, Young-Jun Park, et al.
Cell|August 26, 2020
Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 BindingTyler N Starr, Allison J Greaney, Sarah K Hilton, et al.
Science (New York, N.Y.)|June 28, 2022
Shifting mutational constraints in the SARS-CoV-2 receptor-binding domain during viral evolutionTyler N Starr, Allison J Greaney, William W Hannon, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 26, 2022
Potent monoclonal antibody-mediated neutralization of a divergent Hendra virus variantZhaoqian Wang, Ha V Dang, Moushimi Amaya, et al.
Elife|November 8, 2018
Germline VRC01 antibody recognition of a modified clade C HIV-1 envelope trimer and a glycosylated HIV-1 gp120 coreAndrew J Borst, Connor E Weidle, Matthew D Gray, et al.
Nature|December 18, 2024
Hierarchical design of pseudosymmetric protein nanocagesQuinton M Dowling, Young-Jun Park, Chelsea N Fries, et al.
Biorxiv : the Preprint Server for Biology|January 5, 2021
Structural basis for broad coronavirus neutralizationMaximilian M Sauer, M Alexandra Tortorici, Young-Jun Park, et al.
Viruses|May 10, 2020
Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization AssaysKatharine H D Crawford, Rachel Eguia, Adam S Dingens, et al.
Immunity|October 14, 2020
HIV-1 VRC01 Germline-Targeting Immunogens Select Distinct Epitope-Specific B Cell ReceptorsYu-Ru Lin, K Rachael Parks, Connor Weidle, et al.
Pageof 23